Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion

Tissue Antigens

Volumn 48, Issue 4 I, 1996, Pages 255-264

  Teng, J M C ^a   King, P D ^a   Sadra, A ^a   Liu, X ^a   Han, A ^a   Selvakumar, A ^a   August, A ^b   Dupont, B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

CD28; Cell signaling; Costimulation; Interleukin 2; Mutational analysis; Phosphatidylinositol 3 kinase; T lymphocyte

Indexed keywords

CD28 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; IONOMYCIN; PHENYLALANINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; T LYMPHOCYTE RECEPTOR; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA; T LYMPHOCYTE;

EID: 0029910720     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02643.x     Document Type: Article

References (41)

1. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T cell activation, Immunol Today 1990: 11: 211-216.
2. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993: 11: 191-212.
3. Schwartz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992: 71: 1065-1068.
4. Jenkins MK, Taylor PS, Norton SD, Urdhal KB. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J Immunol 1991: 147: 2461-2466.
5. Koulova L, Clark EA, Shu G, Dupont B. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells. J Exp Med 1991: 173: 759-762.
6. Reiser H, Freeman GJ, Razi-Wolf Z, Gimmi CD, Benacerraf B, Nadler LM. Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T cell receptor/CD3 complex. Proc Natl Acad Sci U S A 1992: 89: 271-275.
7. Freeman GJ, Gribben JG, Boussiotis VA et al. Cloning of B7-2: a CTLA-4 counterreceptor that costimulates human T cell proliferation. Science 1993: 262: 909-911.
8. Lenschow DJ, Huei-Ting Su G, Zuckerman LA et al. Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci U S A 1993: 90: 11054-11058.
9. Harding FA, Allison JP. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med 1993: 177: 1791-1796.
10. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP. CD28-mediated signaling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 1992: 356: 607-609.
11. Tan P, Anasetti C, Hansen JA, et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/ BB1. J Exp Med 1993: 177: 165-173.
12. June CH, Ledbetter JA, Gillespie MM, Lindsten T, Thompson CB. T-cell proliferation involving the CD28 pathway is associated with cyclosporine resistant interleukin 2 gene expression. Mol Cell Biol 1987: 7: 4472-4481.
13. Thompson CB, Lindsten T, Ledbetter JA, et al. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci U S A 1989: 86: 1333-1337.
14. Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of Interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991: 251: 313-316.
15. Fraser JD, Weiss A. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol Cell Biol 1992: 12: 4357-4363.
16. Williams TM, Moolten DM, Makni H, Kim HW, Kant JA, Kamoun M. CD28-stimulated IL-2 gene transcription in Jurkat cells occurs in part transcriptionally and is cyclosporine-A sensitive. J Immunol 1992: 148: 2609-2616.
17. Lindsten T, June CH, Ledbetter JA, Stella G, Thompson CB. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 1989: 244: 339-343.
18. Shahinian A, Pfeffer K, Lee KP, Kundig TM et al. Differential costimulatory requirements in CD28-deficient mice. Science 1993: 261: 609-612.
19. Lenschow DJ, Zeng Y, Thistlewaite A et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig. Science 1992 257: 789-792.
20. Turka LA, Linsley PS, Lin H et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A 1992: 89: 11102-11105.
21. Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA4Ig. Science 1994: 265: 1225-1227.
22. Cheng L, Ashe S, Brady WA et al. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA4. Cell 1992: 71: 1093-1102.
23. Townsend SE, Allison JP. Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 1993: 259: 368-370.
24. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A 1993: 90: 5687-5690.
25. Prasad KVS, Cai Y, Raab M et al. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc Natl Acad Sci U S A 1994: 91: 2834-2838.
26. Truitt KE, Hicks CM, Imboden JB. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J Exp Med 1994: 179: 1071-1076.
27. August A, Dupont B. CD28 of T lymphocytes associates with phosphatidylinositol 3-kinase. Int Immunol 1994: 6: 769-774.
28. Pages F, Ragueneau M, Rottapel R et al. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signaling. Nature 1994: 369: 327-329.
29. Ueda Y, Levine BL, Huang ML et al. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion. Int Immunol 1994: 7: 957-966.
30. Cai Y, Cefai D, Schneider H, Raab M, Nabavi N, Rudd CE. Selective CD28pYMNM mutations implicate phosphatidylinositol 3-kinase in CD86-CD28-mediated costimulation. Immunity 1995: 3: 417-426.
31. Truitt KE, Shi J, Gibson S, Segal LG, Mills GB, Imboden JB. CD28 delivers costimulatory signals independently of its association with phosphatidylinositol 3-kinase. J Immunol 1995: 155: 4702-4710.
32. Ward SG, Wilson A, Turner L, Westwick J, Sansom DM. Inhibition of CD28-mediated T cell costimulation by the phosphoinositide 3-kinase inhibitor wortmannin. Eur J Immunol 1995: 25: 526-532.
33. Lu Y, Phillips CA, Trevillyan JM. Phosphatidylinositol 3-kinase activity is not essential for CD28 costimulatory activity in Jurkat T cells: studies with a selective inhibitor, wortmannin. Eur J Immunol 1995: 25: 533-537.
34. Hutchcroft JE, Franklin DP, Tsai B, Harrison-Findik D, Varticovski L, Bierer B. Phorbol ester treatment inhibits phosphatidylinositol 3-kinase activation by. and association with, CD28, a T-lymphocyte surface receptor. Proc Natl Acad Sci U S A 1995: 92: 8808-8812.
35. Hahn WC, Menzin E, Saito T, Germain RN, Bierer B. The complete sequences of plasmids pFNeo and pMHNeo: convenient expression vectors for high level expression of eukaryotic genes in hematopoietic cell lines. Gene 1993: 127: 267-268.
36. src. Mol Cell Biol 1991: 11: 1972-1977.
37. Walsh JP, Caldwell KK, Majerus PW. Formation of phosphatidylinositol 3-phosphate by isomerization from phosphatidylinositol 4-phosphate. Proc Natl Acad Sci U S A 1991: 88: 9184-9187.
38. Stein PH, Fraser JD, Weiss A. The cytoplasmic domain of CD28 is both necessary and sufficient for costimulation of interleukin-2 secretion and association with phosphatidylinositol 3′-kinase. Mol Cell Biol 1994: 14: 3392-34s02.
39. Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T cell costimulation. Proc Natl Acad Sci U S A 1995: 92: 8891-8895.
40. ras. Eur J Immunol 1995: 25: 1044-1050.
41. Crooks MEC, Littman DR, Carter RH, Fearon DT, Weiss A, Stein PH. CD28 mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation. Mol Cell Biol 1995: 15: 6820-6828.